Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-04

Clinical Trial Update: Seroquel on Glucose Metabolism [Phase 4]

View source ↗

Summary

Phase 4 trial update on quetiapine (Seroquel) and its effects on glucose metabolism in schizophrenia; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED